Update: Q4 Results FY'20 Glenmark Pharmaceuticals Limited (GPL) - a research-led global integrated pharmaceutical company, on Friday announced its financial results for the 4th quarter and year ended March 31, 2020. The company's consolidated revenue for the quarter rose 7.96% to INR 2,767.48 Cr as against INR 2,563.47 Cr a year ago. The Company posted a 36.28% rise in its consolidated net profit to INR 220.3 Cr for the 4th quarter ended March 31, 2020. The drug firm had reported a net
Browsing category Value Pick
Update: Q4 Results FY '20 Private life insurer major HDFC Life Insurance posted its Q4 numbers today after market hours. The company posted a 14.5% Y-O-Y decline in consolidated net profit at INR 311.65 Cr (vs INR 364.88 Cr), impacted by a rise in provisions and a drop in net investment income. Net premium income growth saw a marginal hike to INR 10,475.95 Cr in the March quarter compared to INR 10,251.26 Cr. The total new business premium rose by 15% Y-o-Y to INR 17,239 Cr in FY20. The new
Ipca Laboratories Limited (IPCA) is a fully-integrated Indian pharmaceutical company manufacturing and marketing over 350 formulations and 80 Active Pharmaceutical Ingredients (APIs) covering various therapeutic segments. Ipca Laboratories Limited: Profile Ipca Laboratories was founded by a group of businessmen and medical professionals in the year 1949 under the name of The Indian Pharmaceutical Combine Association Limited. The name of the organization was changed to Ipca Laboratories Ltd
Update: Q2 FY 2019-20 Numbers Metropolis Healthcare Limited, a complete chain of diagnostic companies with its central laboratory in Mumbai, Maharashtra has posted its Q2 FY 2019-20 numbers today. Read standalone details - Revenue from operations stood at INR 172.28 crore in September 2019 up 16.61 percent Y-O-Y basis from INR 147.74 crore in September 2018. Q-O-Q revenues grew by 9.77 percent (INR 156.95 crore for June 2019) Quarterly Net Profit at INR 31.68 crore in September 2019 up 72.87
Update: Q2 FY 2019-20 Numbers GMM Pfaudler Limited - a leading supplier of engineered equipment and systems for critical applications in the global chemical and pharmaceutical markets has presented its quarter 2 numbers today during the market hours. Here are key points - Revenue from operations stood at INR 136.09 Cr in September '19 up 37.22% Y-O-Y from INR 99.18 Cr in September '18. However, the quarter-on-quarter revenue grew by 4.49% (INR 130.25 Cr for June '19) Quarterly Net Profit at
Update: Q2 FY 2019-20 Numbers Kirloskar Brothers Limited (KBL) - a flagship company of the Kirloskar group has posted its Q2 Numbers today during the market hours. Standalone quarterly numbers for Kirloskar Brothers are: Revenue from operations at INR 482.30 Cr in September 2019 down 1.21 percent year-on-year from INR 488.2 Cr in September 2018. However, the Q-O-Q revenue grew by 2.03 percent (INR 472.7 Cr for June 2019) Quarterly Net Profit at INR 94 Cr in September '19 up 46.88 percent
Kiri Industries Limited, popularly known as “KIL” is one of the largest manufacturer and exporter of wide range of Dyes, Intermediates, and Chemicals from India. History: Kiri Industries Limited The company was incorporated in 1998 as Kiri Dyes and Chemicals Private Limited with the setting up of Dyes manufacturing unit at Ahmedabad, Gujarat. Today, KIL is a fully integrated Dyes and Chemicals company and a winner of several CHEMEXCIL and GDMA performance awards. Business Kiri
KEI Industries Limited is an established player in the power cable segment and among the largest cable manufacturing companies in India. History: KEI Industries Ltd KEI was established in the year 1968 as a partnership firm under the name Krishna Electrical Industries, with major business activity of manufacturing house wiring rubber cables. As of inception year itself, the company had started to manufacture Switchboard Cables for DOT. Today, the company has grown into an empire offering

